SBIR/STTR Research Award
DIAGNOSTIC TEST FOR CHRONIC FATIGUE AND FIBROMYALGIA
Award amount
$65,690Program and phase
SBIR · Phase IAward year
1997Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- Not reported
- Recipient company
- AUTOIMMUNE TECHNOLOGIES, LLC
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- NBLGCCAQXG85
- Solicitation number
- Not reported
- Topic code
- Not reported
Research abstract
The long-term goal is to demonstrate that the Anti-Polymer Antibody Assay is diagnostic for chronic fatigue syndrome patients and fibromyalgia patients. In a pilot study 55 % (6/11) of chronic fatigue syndrome patient sera, 71 % (12/17) of fibromyalgia patient sera and 9 % (1/11) sera from healthy normals were seroreactive on the Anti-Polymer Antibody Assay. Therefore, it is hypothesized that the Anti-Polymer Antibody Assay is diagnostic for chronic fatigue syndrome patients and fibromyalgia patients. The purpose of this proposal is to establish the ability of the assay to identify chronic fatigue patient sera and fibromyalgia patient sera in a retrospective multi-center blinded trial. The data generated from the multi-center trial will be used as the basis for the submission of a prospective Phase II multicenter trial. In addition, data from the Phase I trial will be used in the application to the Food and Drug Administration for approval of the Anti-Polymer Antibody Assay as a diagnostic test for chronic fatigue syndrome and fibromyalgia.
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Double Chimeric Peptide Vaccine Feasible for Human Use that Protects against Disseminated Candidiasis caused by medically important Candida species
- Peptide inhibitors of coronavirus entry
- Peptide inhbitors of influenza entry-FAST TRACK
- Peptide inhbitors of influenza entry-FAST TRACK
- Peptide drugs against influenza virus
Research funding history
7 SBIR/STTR records share this UEI (1997–2018). Reported award amounts total $5,476,764. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services